Willis Investment Counsel’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.87M Buy
14,855
+4,741
+47% +$2.19M 0.38% 69
2026
Q1
$4.86M Buy
10,114
+524
+5% +$268K 0.27% 70
2025
Q4
$5.39M Sell
9,590
-2,894
-23% -$1.64M 0.28% 75
2025
Q3
$6.42M Buy
12,484
+234
+2% +$102K 0.35% 72
2025
Q2
$3.84M Buy
12,250
+4,402
+56% +$1.32M 0.23% 74
2025
Q1
$2.39M Sell
7,848
-291
-4% -$97.9K 0.16% 74
2024
Q4
$2.7M Buy
8,139
+137
+2% +$46.5K 0.18% 73
2024
Q3
$2.67M Buy
8,002
+300
+4% +$114K 0.17% 73
2024
Q2
$3.17M Buy
7,702
+71
+0.9% +$28.1K 0.22% 73
2024
Q1
$3.08M Sell
7,631
-1,843
-19% -$648K 0.21% 74
2023
Q4
$2.9M Sell
9,474
-37
-0.4% -$9.99K 0.2% 77
2023
Q3
$2.3M Sell
9,511
-637
-6% -$163K 0.17% 78
2023
Q2
$2.44M Sell
10,148
-457
-4% -$94.9K 0.16% 81
2023
Q1
$1.99M Sell
10,605
-1,200
-10% -$248K 0.13% 80
2022
Q4
$2.51M Sell
11,805
-170
-1% -$34K 0.16% 81
2022
Q3
$1.88M Sell
11,975
-7,609
-39% -$1.21M 0.14% 84
2022
Q2
$2.93M Sell
19,584
-37
-0.2% -$5.36K 0.18% 83
2022
Q1
$3.21M Buy
19,621
+6,223
+46% +$1.03M 0.17% 81
2021
Q4
$2.92M Buy
13,398
+45
+0.3% +$9.42K 0.15% 81
2021
Q3
$2.53M Buy
13,353
+7,406
+125% +$1.35M 0.14% 85
2021
Q2
$1.05M Buy
5,947
+430
+8% +$74.2K 0.06% 96
2021
Q1
$905K Buy
+5,517
New +$844K 0.06% 98

Other funds holding MEDP

Willis Investment Counsel's MEDP Position: Q2 2026 in Review

Willis Investment Counsel increased its Medpace (MEDP) stake by 47% in Q2 2026, buying an estimated $2.19M and bringing the position to 14,855 shares worth $7.87M. The position accounts for 0.38% of the portfolio, ranked #69.

Willis Investment Counsel first reported a position in MEDP in Q1 2021 and has held it in 22 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Willis Investment Counsel held 14,855 shares of Medpace worth $7.87M as of Q2 2026.
  • Willis Investment Counsel bought 4,741 Medpace shares in Q2 2026, an estimated $2.19M.
  • Medpace made up 0.38% of Willis Investment Counsel's portfolio in Q2 2026, its #69 holding.
  • Willis Investment Counsel first reported a position in Medpace in Q1 2021 and has held it in 22 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.